EMA Update: 25 Human Drugs at Risk of Brexit Supply Disruptions

International Pharmaceutical Regulatory Monitor
A A
The EMA lowered its estimate for the number of centrally authorized drugs that may face post-Brexit supply disruptions from 108 to 39 — including 25 human medicines.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00